The (Ancient) Medicinal Science of Amanita muscaria
What four thousand years of traditional medicine got right about the fly agaric
It is the most recognized mushroom in the world with its scarlet cap, white spots, and fairy-tale silhouette. It has been a staple of Christmas cards and Mario games for decades. It has also, for most of that time, been misclassified.
Western science filed Amanita muscaria, the fly agaric, under a single label of poisonous. That label was not entirely wrong, but it is incomplete. Across traditional plant medicine, neuroscience, and the growing community of careful self-experimenters, a different picture is emerging: a mushroom with a real, if still largely unexplored, case for therapeutic use.
Pain relief. Neuroprotection. Sleep. Anxiety. The evidence is early and the risks are real, but the research questions are finally being asked—so let’s dig in.
A different molecule
Most psychedelics work through serotonin. Psilocybin, LSD, and DMT all hit the same receptor in the brain, producing the flooded, hyperconnected states that have come to define the modern psychedelic renaissance. Muscimol, the principal active compound in Amanita muscaria, does none of that.
Muscimol works on the brain’s GABA system; the same system targeted by alcohol, benzodiazepines, and barbiturates. Where psilocybin “turns the volume up,” muscimol turns it down, acting as a brake on the central nervous system with effects concentrated deep in the brain’s processing centers. The result, as longtime users consistently describe it, is something quieter and more inward than a psilocybin trip. Sedative, dreamlike, and felt in the body.
This pharmacological distinction matters. The GABA system governs pain modulation, anxiety, sleep architecture, and neuroprotection. And muscimol, it turns out, touches all of them.
What the shamans already knew
The ethnopharmacological record on fly agaric is ancient and consistent. Linguistic analysis of North Asian languages from around 4000 BCE suggests the roots of the words for “drunkenness” and Amanita muscaria were one and the same. Among the Koryak people of the Kamchatka Peninsula of eastern Russia, it was used topically— pounded into a soft, moist paste for joint pain and inflammation—and orally, for anxiety relief and as a stimulant for endurance. Mid-19th century accounts describe Koryak men reporting dramatically increased stamina after consuming dried fly agaric, capable of working through what felt like three men’s labor in a single day.
Across Siberia, Scandinavia, and Eastern Europe, the therapeutic applications are aligned: pain relief, anti-inflammatory, anti-anxiety, sleep aid. The tradition never stopped. The research just never started.
One piece of preparation knowledge that turns out to be scientifically significant: Siberian shamans dried their mushrooms over fire before consumption. Drying and heating trigger decarboxylation—a process that converts ibotenic acid, the mushroom’s more toxic compound, into muscimol. The conversion is partial, not complete, but it meaningfully shifts the ratio in muscimol’s favor. The shamans were optimizing their extract without a laboratory. Modern users who neglect this step and eat Amanita muscaria raw encounter something quite different: sweating, nausea, disorientation. The preparation is the medicine.
A peer-reviewed study published in Roczniki Kulturoznawcze (Annals of Culturology) confirmed what anthropologists had long documented: that the mushroom was used among the Koryak for a range of therapeutic purposes including pain management, skin conditions, rheumatism, and nervous system disorders, and that folk medicine use persists in the community today.